Biotech

Naoki Okamura
Pharma

Astellas CEO resists 'rescue BD' as Xtandi patent cliff nears

With Xtandi set to lose U.S. patent protection next year, Astellas’ CEO fielded questions this week about his company’s BD strategy ahead of the loss.
Angus Liu Jan 15, 2026 10:42am
Union Square in San Francisco during JPM 2026
Favicon Fierce Biotech

JPM26: Sanofi looks ahead to lingering US policy hurdles

Jan 14, 2026 2:28pm
Gilead Sciences Women HIV Movement campaign
Favicon Fierce Biotech

JPM26: Gilead eyes new deals from a 'position of strength'

Jan 14, 2026 3:30am
Boerner

Bristol Myers CEO pledges to 'cast a broad net' in dealmaking

Jan 12, 2026 4:28pm
Gene Therapy of treatment and adjustment of DNA

Acuitas takes majority stake in Montreal-based RNA manufacturer

Jan 8, 2026 9:12am
HIV AIDS PREP
Favicon Fierce Biotech

Study finds HIV can evolve to resist lenacapavir—at a cost

Jan 7, 2026 2:00pm